[
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market",
    "url": "https://finnhub.io/api/news?id=778774442f46028724901b65e692ee7e18bcaaf8699efd9cba4000a1d8bdf17f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731429360,
      "headline": "Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market",
      "id": 131414713,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market",
      "url": "https://finnhub.io/api/news?id=778774442f46028724901b65e692ee7e18bcaaf8699efd9cba4000a1d8bdf17f"
    }
  },
  {
    "ts": null,
    "headline": "Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets",
    "summary": "BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO), through its subsidiary Life Technologies Corporation (“Thermo Fisher”), a world leader in supplying life sciences solutions and services. The collaboration agreement will enable Mainz B",
    "url": "https://finnhub.io/api/news?id=82b16941f2314b6f23da0011be98d65e0b23bf2294ca24592eba855347c00c14",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731420000,
      "headline": "Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets",
      "id": 131305735,
      "image": "https://media.zenfs.com/en/globenewswire.com/fa079afc58b5fef8ae5aa677600f9292",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO), through its subsidiary Life Technologies Corporation (“Thermo Fisher”), a world leader in supplying life sciences solutions and services. The collaboration agreement will enable Mainz B",
      "url": "https://finnhub.io/api/news?id=82b16941f2314b6f23da0011be98d65e0b23bf2294ca24592eba855347c00c14"
    }
  }
]